Celcuity CELC
NASDAQ CELC
$95.70 -0.73 (-0.76%)
As of: Sep 4, 2026 · 3:59 PM EDT

Celcuity (CELC) Change in Account Payables (2016 - 2025)

Celcuity's (CELC) quarterly Change in Account Payables came in at -$4.8 million in Q4 2025, down 2273.42% YoY from $222000.0 in Q4 2024, and down 8672.73% on a QoQ basis from -$55000.0 in Q3 2025.

Analysis

Celcuity (CELC) Change in Account Payables (2016 - 2025) Analysis & Trends

Celcuity (CELC) has 10 years of Change in Account Payables data on file, last reported at -$4.8 million in Q4 2025.

  • Quarterly Change in Account Payables fell 2273.42% year-over-year to -$4.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$3.0 million (down 170.44% YoY) and the FY2025 annual result came in at -$3.0 million, down 170.44% from the prior year.
  • Change in Account Payables slipped to -$4.8 million in Q4 2025, from -$55000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $2.9 million in Q3 2024 to a low of -$4.8 million in Q4 2025.
  • A 5-year average of $304481.3 and a median of $301047.0 in 2021 frame the typical range for Change in Account Payables.
  • Annual changes were most pronounced in 2021 — Change in Account Payables jumped 19904.03% — and 2025, when it plunged 2273.42%.
  • Tracing CELC's Change in Account Payables over 5 years: stood at -$247449.0 in 2021, then plunged by 92.4% to -$476096.0 in 2022, then fell by 26.3% to -$601309.0 in 2023, then soared by 136.92% to $222000.0 in 2024, then sank by 2273.42% to -$4.8 million in 2025.
  • The last three Change in Account Payables figures came in at -$4.8 million (Q4 2025), -$55000.0 (Q3 2025), and $1.2 million (Q2 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -66.70 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -8.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 5.03 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 37.53 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Celcuity 5.25 Bn 5.25 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -4.83 Mn
Sep 30, 2025 -55,000.00
Jun 30, 2025 1.23 Mn
Mar 31, 2025 613,000.00
Dec 31, 2024 222,000.00
Sep 30, 2024 2.91 Mn
Jun 30, 2024 945,000.00
Mar 31, 2024 238,000.00
Dec 31, 2023 -601,309.00
Sep 30, 2023 2.61 Mn
Jun 30, 2023 429,636.00
Mar 31, 2023 -8,545.00
Dec 31, 2022 -476,096.00
Sep 30, 2022 848,031.00
Jun 30, 2022 192,054.00
Mar 31, 2022 513,091.00
Dec 31, 2021 -247,449.00
Sep 30, 2021 1.12 Mn
Jun 30, 2021 364,094.00
Mar 31, 2021 73,924.00